← Leaderboards
Il-Man Kim
Augusta University
$4,089,783
Attributed
$4,089,783
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $637.1K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,089,783 · 3
By mechanism
R01$4,089,783 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Adrenergic Receptor”
- Walter J Koch · Duke University$26,804,343
- Brian K Kobilka · Stanford University$21,509,981
- Howard A Rockman · University Of California San Diego$19,177,720
- Bruce M Psaty · University Of Washington$17,027,178
- Jeffrey L Benovic · Thomas Jefferson University$15,360,655
- Robert J Lefkowitz · Duke University$13,679,999
Research focus
Adrenergic ReceptorMyocardial IschemiaMyocardialSignal TransductionMicrornasBeta-ArrestinMissionInjuryMyocardial InfarctionNovel Therapeutic InterventionHeart DiseasesHeartMediatingCardiac MyocytesCardiacInnovationCarvedilolHeart FailureIn VitroFunctional DisorderAging PopulationMorbidity - Disease RateLaboratoriesLigands
Grant awards (11)
Deciphering the novel regulatory mechanisms of neovascularization, cardiomyocyte survival, and endothelial cell-cardiomyocyte crosstalk in myocardial infarction$637,126
R01 · FY2025 · HL · contact PI
Identifying novel pathways targeting endothelial-to-mesenchymal transition during heart failure$385,371
R01 · FY2022 · HL · contact PI
Identifying novel pathways targeting endothelial-to-mesenchymal transition during heart failure$388,449
R01 · FY2021 · HL · contact PI
Identifying novel pathways targeting endothelial-to-mesenchymal transition during heart failure$391,161
R01 · FY2020 · HL · contact PI
Identifying novel pathways targeting endothelial-to-mesenchymal transition during heart failure$393,750
R01 · FY2019 · HL · contact PI
Beta-arrestin signaling and microRNA biogenesis in cardioprotection$326,982
R01 · FY2018 · HL · contact PI
Beta-arrestin signaling and microRNA biogenesis in cardioprotection$54,936
R01 · FY2018 · HL · contact PI
Beta-arrestin signaling and microRNA biogenesis in cardioprotection$380,000
R01 · FY2017 · HL · contact PI
Beta-arrestin signaling and microRNA biogenesis in cardioprotection$380,000
R01 · FY2016 · HL · contact PI
Beta-arrestin signaling and microRNA biogenesis in cardioprotection$374,300
R01 · FY2015 · HL · contact PI
Beta-arrestin signaling and microRNA biogenesis in cardioprotection$377,708
R01 · FY2014 · HL · contact PI